Oxygen Biotherapeutics extends big rally

Another day, another rally for Oxygen Biotherapeutics (OXBT +35.1%).

Volume is nearly double the 10-day average just a little over an hour into trading.

Today's gains follow a monster session on Monday and with this morning's move, the stocks is now up some 375% since last Wednesday.

Reality check: YTD performance including today's rally is -44%.

Comments (4)
  • blainerunner
    , contributor
    Comments (12) | Send Message
    The reality check mainly pertains to the company prior to its acquisition of Levosimenden from Phyxius.


    All signs point to Levo being worth 300 to 600 million in the US market upon FDA approval. FDA approval is a big "if. The drug could be rejected, but OXBT's current market cap is 35 million, which is one tenth the value of the low end of projected sales of Levo. Mu hunch is that OXBT will hit a cap of 100 million before anybody starts to really consider the chances of FDA approval. Also, OXBT has a drug for military brain trauma in trials that are currently suspended by the FDA as part of a general suspension of all drugs of that class (nothing unique to OXBT's compound).
    5 Nov 2013, 11:36 AM Reply Like
  • Barna Financial
    , contributor
    Comments (26) | Send Message
    just looking over the charts for OXBT, it once traded over $300 per share. I have done a lot of reading on Levo and it already being a widely used approved drug in over 50 countries, I think the chances are high for the FDA approval, but who knows… jumped in at $3.69 per share, hesitant as to when to get out. so far so good. Good luck to all
    5 Nov 2013, 01:09 PM Reply Like
  • hawright
    , contributor
    Comment (1) | Send Message
    I have owned OXBT since 09 and it has never above $9.00. Seeking Alpha shows it @125 around that time. It didn't happen
    5 Nov 2013, 02:36 PM Reply Like
  • Barna Financial
    , contributor
    Comments (26) | Send Message
    OXBT showed 8.4 million in cash today, reported by Acquiremedia, i feel another rally coming up...
    8 Nov 2013, 11:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs